
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Study Phase : Preclinical
Sponsor : Souffle Therapeutics
Deal Size : $200.0 million
Deal Type : Series A Financing
RNA biotech Soufflé rises with $200M and Big Pharma partners
Details : The Series A financing will support the development of an undisclosed oligonucleotide product targeting metabolism.
Product Name : Undisclosed
Product Type : Oligonucleotide
Upfront Cash : Undisclosed
October 07, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Highest Development Status : Preclinical
Sponsor : Souffle Therapeutics
Deal Size : $200.0 million
Deal Type : Series A Financing
